[The contribution of cytogenetics to the evaluation of residual disease in malignant hemopathies].

Pathol Biol (Paris)

Laboratoire d'Hématologie-Cytogénétique, Centre Hospitalier Régional, Saint-Priest-en-Jarez, France.

Published: January 1988

Autologous bone marrow transplantation is now a major tool in the treatment of human leukemias and lymphomas. Evaluation of residual disease by standard cytological methods is difficult. Cytogenetics provide clonal markers which are specific features of leukemic cells. Detection of minimal disease by chromosomal methods is possible in acute leukemias, it requires karyotyping of a few hundred metaphases from a short term culture. A preselection of the material to be examined will improve the degree of sensitivity of the method.

Download full-text PDF

Source

Publication Analysis

Top Keywords

evaluation residual
8
residual disease
8
[the contribution
4
contribution cytogenetics
4
cytogenetics evaluation
4
disease malignant
4
malignant hemopathies]
4
hemopathies] autologous
4
autologous bone
4
bone marrow
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!